KHKaren Hay

Karen Hay

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Karen Hay has a total of 125 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Correlation of 3T Magnetic Resonance Imaging Neurogram to Histology for Large Nerve Perineural Spread From Cutaneous Squamous Cell Carcinoma of the Head and Neck

    by Mai N. Tran, Ryan Sommerville, Karen Hay, Touraj Taheri, Jennifer Gillespie, Charles Lin

    Introduction: Cutaneous Squamous Cell Carcinoma (cSCC) is a major health issue in Australia. Perineural spread (PNS) in cSCC carries a worse prognosis. Magnetic Resonance Imaging (MRI) neurogram is the best imaging modality to detect and define the zonal extent of PNS, although histology remains the diagnostic gold standard. Aims: Investigate the agreement between the detection of PNS on MRI and the histology of the resected nerve. We also assess the agreement of MRI zoning with the histological zoning based on William's definition and our department's modified classification system. Methods: We conducted a retrospective review of consecutive patients with PNS from cSCC of the head and neck. Patients included had PNS on MRI neurogram and histology of the suspected nerve for review. Results: Seventy patients were included, with 90 suspected involved nerves reviewed. Two nerves considered involved with PNS on MRI were not involved on histology. The positive predictive value of MRI neurogram was 98%. Three nerves were negative on MRI but positive on histology, resulting in a 97% positive agreement. The observed zonal agreement was 83% based on William's zonal classification and 69% with our institution's modified zonal classification system. With the latter system, the agreement for zones 1, 2a and 2b PNS was 85%, 50% and 40% respectively. Conclusion: 3T MRI neurogram is an effective modality to detect PNS in cSCC of the head and neck region. The accuracy of MRI to sub‐define zones 2a and 2b requires further study.

  • Open Access

    Invasive Fungal Infections in Heart Transplants: A 10‐Year, Single Centre Retrospective Cohort Study From Subtropical Australia

    by Angus Lane, Karen Hay, John McNamara, Alex Chaudhuri, Andrew Burke, Robert Horvath, Maryam Khorramshahi Bayat, Kanthi Vemuri

    Background: Invasive fungal infections (IFIs) are a major cause of morbidity and mortality in solid organ transplant recipients. However, their epidemiology in Australian heart transplant cohorts remains poorly defined. We aimed to determine the incidence, microbiological profile, diagnostic performance, and survival outcomes associated with IFIs in heart transplant recipients. Methods: We conducted a retrospective cohort study of all heart transplant patients who were diagnosed with an IFI between January 1, 2014 and February 29, 2024 at a single center in Queensland, Australia. Patient characteristics, details of transplant hospitalization, antifungal prophylaxis, microbiology, and treatment of fungal infections were described. Results: Of 73 patients with suspected IFI, 48 met criteria for possible 19% ( n = 9), probable 27% ( n = 13), or proven 54% ( n = 26) infection. Aspergillus 33% ( n = 16), Candida 17% ( n = 8), Scedosporium 13% ( n = 6), and polymicrobial infections 8% ( n = 4) were most common. Median time to IFI diagnosis was 7 months post‐transplant. Of 148 patients who received heart transplants at the center between January 2014 and February 2024, 32 developed IFI; estimated incidence was 49 (95% CI: 35–70) per 1000 person years. Among those who died ( n = 21), median time from transplant to death was 5.75 years. Baseline Charlson comorbidity index was the only variable significantly associated with all‐cause mortality ( p = 0.041). Conclusion: IFIs in heart transplant recipients frequently occur beyond the first year posttransplant. Higher Charlson scores were associated with reduced survival. These findings support the need for tailored prophylaxis strategies and improved diagnostic algorithms in preventing posttransplant IFI. image

  • Open Access

    Use of sensory processing information in the diagnosis of autism spectrum disorder and attention deficit hyperactivity disorder in children at an Australian community hospital

    by Annabelle Marozza, Karen Hay, Thuy Frakking

    Introduction: The provision of sensory processing information is one aspect of occupational therapy involvement in diagnostic assessment for autism spectrum disorder and attention deficit hyperactivity disorder. The aim of this study was to retrospectively compare SHORT Sensory Profile 2 results of children with suspected diagnoses and assess the discriminatory ability of modified scales of SHORT Sensory Profile 2 to identify diagnostic criteria.Method: This study involved a retrospective chart audit of SHORT Sensory Profile 2 results and paediatrician letter of diagnosis (N = 92) for children aged 6–13 years who had multidisciplinary diagnostic assessment through outpatient paediatric service.Consumer and Community Involvement: No consumers participated in the study design or analysis. Study involved retrospective analysis of de‐identified results from caregiver assessments.Results: Forty nine per cent of children in study sample had confirmed diagnosis of attention deficit hyperactivity disorder, and 26% had diagnosis of autism spectrum disorder. Average percentage scores for both behavioural and sensory components of the SHORT Sensory Profile 2 were highest amongst children with a diagnosis of autism spectrum disorder, as well as higher classification for avoiding and seeking quadrants. In relation to modified scales, Cronbach's alpha indicated high internal consistency for inattention (0.84) and social communication and interaction (0.86). Based on the ROC analyses, the discriminatory ability when all the modified scales are used in combination ranged from poor (original four quadrants to distinguish ADHD vs no diagnosis: AUC = 0.59) to good (ASD vs ADHD; AUC = 0.82; ASD vs no diagnosis (AUC = 0.81).Conclusion: Results of this study highlight the need for more rigorous investigation for validation of modified scales and consensus within occupational therapy and multidisciplinary team in relation to reporting of sensory processing information and contribution to diagnostic criteria.PLAIN LANGUAGE SUMMARY: Many children with attentional difficulties or autism require information from occupational therapists about their sensory issues to help inform and identify behaviours of concern. This study looked at how a sensory processing screening tool can identify traits related to attentional difficulties and autism in children. Seventy‐eight medical charts of children from a community hospital were reviewed. This study showed that information from the sensory processing screening tool related to attention and social communication traits. Clinicians can consider using information from a sensory processing screening tool in combination with other assessments to contribute to the identification of attention difficulties and autism in children.


  • Open Access

    Excess Bed Days and Hospitalization Costs Associated With 30‐Day Complications Following Catheter Ablation of Atrial Fibrillation

    by Linh Ngo, Russell Denman, Karen Hay, Billingsley Kaambwa, Anand Ganesan, Isuru Ranasinghe

    Background: The incidence and type of complications following catheter ablation of atrial fibrillation have been extensively examined, but the impact associated with these complications on the length of stay and hospitalization costs is unknown. Methods and Results: This cohort study included 20 117 adult patients (mean age 62.6±11.4 years, 30.3% women, median length of stay 1 day [interquartile range 1–2 days]) undergoing atrial fibrillation ablation in financial years 2011 to 2017 in Australia with available cost data from the National Hospital Cost Data Collection, which determines government reimbursement of health services provided. The primary outcome was the costs associated with complications occurring up to 30 days postdischarge adjusted for inflation to 2021 Australian dollars. We used generalized linear models to estimate the increase in length of stay and cost associated with complications, adjusting for patient characteristics. Within 30 days of hospital discharge, 1151 (5.72%) patients experienced a complication with bleeding (3.35%) and pericardial effusion (0.75%) being the most common. On average, the occurrence of a complication was associated with an adjusted 3.3 (95% CI, 3.1–3.6) excess bed days of hospital care (totaling 3851 days), and a $7812 (95% CI, $6754–$8870) increase in hospitalization cost (totaling $9.0 million). Most of the total excess cost was attributable to bleeding ($3.8 million, 41.9% of total excess cost) and pericardial effusion ($1.6 million, 18.2%). Conclusions: Complications following atrial fibrillation ablation were associated with significant increase in length of stay and hospitalization costs, most of which were attributable to bleeding and pericardial effusion. Strategies to improve procedural safety and reduce health care costs should focus on these complications.


  • Open Access

    Prehospital Activation of the Cardiac Catheterization Laboratory in ST‐Segment–Elevation Myocardial Infarction for Primary Percutaneous Coronary Intervention

    by Michael L. Savage, Karen Hay, William Vollbon, Tan Doan, Dale J. Murdoch, Christopher Hammett, Rohan Poulter, Darren L. Walters, Russell Denman, Isuru Ranasinghe, et al.

    Background: Prehospital activation of the cardiac catheter laboratory is associated with significant improvements in ST‐segment–elevation myocardial infarction (STEMI) performance measures. However, there are equivocal data, particularly within Australia, regarding its influence on mortality. We assessed the association of prehospital activation on performance measures and mortality in patients with STEMI treated with primary percutaneous coronary intervention from the Queensland Cardiac Outcomes Registry (QCOR). Methods and Results: Consecutive ambulance‐transported patients with STEMI treated with primary percutaneous coronary intervention were analyzed from January 1, 2017 to December 31, 2020 from the QCOR. The total and direct effects of prehospital activation on the primary outcomes (30‐day and 1‐year cardiovascular mortality) were estimated using logistic regression analyses. Secondary outcomes were STEMI performance measures. Among 2498 patients (mean age: 62.2±12.4 years; 79.2% male), 73% underwent prehospital activation. Median door‐to‐balloon time (34 minutes [26–46] versus 86 minutes [68–113]; P P P P P P P P <0.001). Conclusions: Prehospital activation of cardiac catheterization laboratory for primary percutaneous coronary intervention was associated with significantly shorter time to reperfusion, achievement of STEMI performance measures, and lower 30‐day and 1‐year cardiovascular mortality.


  • Open Access

    Prehospital activation of the cardiac catheterisation laboratory in ST-segment elevation myocardial infarction (STEMI) for primary percutaneous coronary intervention (PCI)

    by Michael L Savage, Karen Hay, William Volbon, Tan Doan, Dale Murdoch J, Christopher Hammett, Rohan Poulter, Darren L Walters, Russell Denman, Isuru Ranasinghe, et al.

    Background: Prehospital activation of the cardiac catheter laboratory is associated with significant improvements in ST-segment elevation myocardial infarction (STEMI) performance measures. However, there is equivocal data, particularly within Australia regarding its influence on mortality. We assessed the association of prehospital activation on performance measures and mortality in STEMI patients treated with primary percutaneous coronary intervention (PCI) from the Queensland Cardiac Outcomes Registry (QCOR). Methods: Consecutive ambulance transported STEMI patients treated with primary PCI were analysed from 1 st January 2017 to 31 st December 2020 from the QCOR. The total and direct effects of prehospital activation on the primary outcomes (30-day and 1-year cardiovascular mortality) were estimated using logistic regression analyses. Secondary outcomes were STEMI performance measures. Results: Among 2498 patients (mean age: 62.2 ± 12.4 years; 79.2% male), 73% underwent prehospital activation. Median door-to-balloon (DTB) time (34mins [26-46] vs 86 mins [68-113]; p<0.001), first-electrocardiograph-to-balloon (ECGTB) time (83.5 mins [72-98] vs 109 mins [81-139]; p<0.001), and proportion of patients meeting STEMI targets (DTB<60mins 90% vs 16%; p<0.001), ECGTB<90mins (62% vs 33%; p<0.001) were significantly improved with prehospital activation. Prehospital activation was associated with significantly lower 30-day (1.6% vs 6.6%; p<0.001) and 1-year cardiovascular mortality (2.9% vs 9.5%; p<0.001). After adjustment, no prehospital activation was strongly associated with increased 30-day (OR: 3.6; 95%CI: 2.2-6.0, p<0.001) and 1-year cardiovascular mortality (OR: 3.0 (95%CI:2.0-4.6; p<0.001). Conclusions: Prehospital activation of cardiac catheterisation laboratory for primary PCI was associated with significantly shorter time to reperfusion, achievement of STEMI performance measures and lower 30-day and 1-year cardiovascular mortality. Clinical Perspective: In patients who suffer STEMI, prehospital activation of the cardiac catheter laboratory and initiation of medical therapy is associated with shorter time to reperfusion, greater achievement of performance measures and lower cardiovascular mortality This study adds to the existing literature and demonstrates that a standardised prehospital activation strategy can be implemented on a large scale Widespread implementation of standardised prehospital activation strategies may offer opportunity to expedite STEMI care and improve outcomes

  • Open Access

    Evaluation of clinical pharmacist-led medication review in patients referred to a hospital-based residential aged care support service

    by June Chan, Richard Bolitho, Karen Hay, Faith Yong

    Background Hospital-based Residential Aged-care Support Service (RaSS) teams typically consist of doctors and nurses who provide emergency and hospital substitutive care to residents of residential aged care facilities (RACF). While evidence supports the role of community pharmacist-led medication reviews in RACFs, there is limited literature evaluating the role of pharmacists integrated into aged care support teams. The purpose of this study was to analyse the effect of RaSS pharmacist-led medication reviews on polypharmacy, drug burden index, potentially inappropriate medications and potential prescribing omissions for residents living in RACFs. Methods Residents were referred to a Residential Aged-care Support Service pharmacist for medication review over a 12-month period. Medication-related problems and recommendations identified by the pharmacist were communicated to the resident’s general practitioner and RaSS medical practitioner for review. Residents’ medication histories were obtained at baseline and at one-month post-intervention. The number of medications prescribed to RACF residents, their associated drug burden indices, potentially inappropriate medications, and potential prescribing omissions identified at baseline and post-intervention were compared to evaluate the effects of RaSS pharmacist-led medication reviews. Results 175 residents with a mean age of 84 years were referred to a hospital-based Residential Aged-care Support Service pharmacist for medication review. Median time to post-intervention evaluation was 29 days. The mean total number of medications prescribed were reduced from 18 medications at baseline to 17 medications post-intervention (p<0.001). The mean drug burden index score was reduced from 1.53 (at baseline) to 1.35 post-intervention (p<0.001). There were more residents that experienced a decrease in inappropriate medications (p<0.001) and prescribing omissions (p=0.008) compared to those that had an increase. Conclusions This study suggests that medication reviews performed by pharmacists embedded in hospital-based residential aged care support services may improve medication use and prescribing practices in aged care. Future research needs to be prioritised to corroborate this.

  • A protocol of an international validation study to assess the clinical accuracy of the eDIS-ICU delirium screening tool

    by Oystein Tronstad, Sue Patterson, Anna-Liisa Sutt, India Pearse, Karen Hay, Keibun Liu, Kei Sato, Yuji Koga, Ayaka Matsuoka, Takashi Hongo, et al.


  • Open Access

    State‐wide prevalence of pressure injury in intensive care versus acute general patients: A five‐year analysis

    by Paul Fulbrook, Josephine Lovegrove, Karen Hay, Fiona Coyer

    Aim: The aim of this study was to analyse prevalence of pressure injury in intensive care versus non‐intensive care patients.Background: Hospital‐acquired pressure injury is an enduring problem. Intensive care patients are more susceptible due to multiple risk factors. Several studies have indicated that intensive care patients are more likely than general patients to develop pressure injuries.Design: Secondary data analysis.Methods: Eighteen general hospitals with intensive care units were included. The sample included all consenting patients. Logistic regression modelling was used to derive prevalence and effect estimates. STROBE reporting guidelines were followed.Results: The sample comprised 15,678 patients; 611 were in intensive care. The crude prevalence estimate of hospital‐acquired pressure injury was 9.6% in intensive care and 2.1% in non‐intensive care patients. The ≥Stage II hospital‐acquired prevalence estimate in was 8.6% intensive care and 1.2% in non‐intensive care patients. Intensive care patients were at markedly increased risk of hospital‐acquired pressure injury compared with non‐intensive care patients, with risk persisting after adjusting for pressure injury risk score. Risk of ≥ Stage II hospital‐acquired pressure injury was further elevated. Intensive care patients had a higher pressure injury risk level and developed a greater proportion of severe hospital‐acquired pressure injuries than non‐intensive care patients. In intensive care, most hospital‐acquired pressure injuries were found on the sacrum/coccyx and heels.Conclusions: There were significant differences between the hospital‐acquired pressure injury prevalence of intensive care versus non‐intensive care patients, which is consistent with previous studies. Overall, the prevalence of hospital‐acquired pressure injury in intensive care is relatively high, indicating that their prevention should remain a high priority within the intensive care setting.Relevance to Clinical Practice: These results may be used for benchmarking and provide a focus for future education and practice improvement efforts.Patient or Public Contribution: Neither patients nor the public were directly involved in the project.